Products

EchoNext
Pathway Labs
Cardiology AI
EchoNext is an FDA-cleared AI tool from Pathway Labs that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension.

See all 1 product →

About Pathway Labs

Pathway Labs is a healthcare AI company focused on transforming clinical workflows and improving patient outcomes through advanced artificial intelligence. Their core offering involves AI-powered platforms designed to integrate seamlessly into existing healthcare systems, providing actionable insights and automating routine tasks. This allows physicians to dedicate more time to direct patient care and complex decision-making, reducing administrative burden and potential for burnout. The company’s solutions are built to be interoperable and scalable, addressing critical needs in areas such as diagnostic support, personalized treatment planning, and operational efficiency within healthcare organizations.

Pathway Labs emphasizes the development of explainable AI, ensuring that their algorithms provide transparent and interpretable results, which is crucial for physician trust and clinical adoption. Their technology aims to augment human intelligence rather than replace it, offering tools that can analyze vast amounts of medical data, identify patterns, and flag anomalies that might be missed by human observation alone. By leveraging machine learning and natural language processing, Pathway Labs seeks to unlock new efficiencies and insights across the healthcare continuum, from early disease detection to chronic disease management.

What Physicians Need to Know

Specialization: AI for Clinical Decision Support
Pathway Labs specializes in developing AI tools that provide clinical decision support, aiming to assist physicians in making informed treatment decisions. Their AI model, EchoNext, has received FDA approval for detecting six types of hidden structural heart disease from electrocardiograms. They also focus on creating AI systems that offer transparent, just-in-time reasoning, linking recommendations to expert-vetted guidelines and drug references.
Specialization: Advanced Diagnostic Services
Pathway Diagnostic Laboratories, a related entity, offers comprehensive genetic testing using advanced technologies like PCR testing and Next Generation Sequencing (NGS). They provide precise and timely results for disease detection, monitoring, and treatment planning, with a focus on accuracy, speed, and patient safety.
Key Differentiator: Transparent and Evidenced-Based AI
Pathway's AI stands out due to its transparent just-in-time reasoning pipeline, which combines retrieval-augmented generation (RAG) with chain-of-thought (CoT) analysis and agentic tool calling. This architecture allows the AI to evaluate multiple information sources, identify knowledge gaps, generate follow-up questions, and apply clinical scoring rules, all while revealing its step-by-step reasoning and linking recommendations to verifiable evidence.
Key Differentiator: High Accuracy and Performance
Pathway's proprietary large-language model (LLM), 'Deep,' achieved a 96% accuracy rate on a validated set of United States Medical Licensing Examination (USMLE) questions, outperforming other medical AI systems and generalist systems.
Technology Stack: Live Data Framework for AI
Pathway Labs utilizes a 'Live Data Framework' designed for real-time data processing and AI. This framework facilitates data ingestion from over 300 sources with automatic synchronization, enabling the creation of applications that serve real-time features, live vector search, and anomaly alerts. It aims to provide accurate AI insights from large volumes of connected documents and data without requiring vector databases or a complex stack.
Technology Stack: Compliance-First AI Governance
Pathway Labs builds compliance-first applications, data pipelines, and AI governance with features like role-based access, policy rules, and event logging built into the platform. This ensures secure, stable, and compliant systems, particularly important for sensitive environments and mission-critical organizations.
Physician Tip

For physicians, Pathway Labs offers AI tools that can significantly enhance diagnostic capabilities, particularly in cardiology with FDA-approved tools like EchoNext for structural heart disease detection. The transparent and evidence-based reasoning of their AI models means you can trust the recommendations, as they are linked to expert-vetted guidelines and drug references. The high accuracy on medical licensing exams also suggests a reliable tool for clinical decision support. Additionally, for those utilizing genetic testing, Pathway Diagnostic Laboratories provides comprehensive and timely results to support personalized care. The integration capabilities with existing systems can reduce administrative burden and streamline workflows, allowing more time for patient care.

Pathway Labs' MyPath platform integrates with Learning Management Systems (LMS) and third-party Financial Aid processors, syncing data in real-time or nightly to reduce administrative burden. They also offer integrations with Dropbox Sign for e-signatures and a Leads API for syncing inquiries from websites. For laboratory operations, Pathways LIS supports various inputs like web APIs, QR codes, HL7 file uploads, and Excel batch uploads, and outputs to printed reports, faxes, emails, SMS, WhatsApp, and Electronic Health Record Sharing Systems (eHealth). Their partnership with OpenEvidence will also expand the reach of their AI tools, as OpenEvidence is widely used by U.S. physicians and offers clinical decision support, real-time documentation, and medical literature synthesis.

Products by Pathway Labs

1 product in the directory

EchoNext
Pathway Labs
Cardiology AI
EchoNext is an FDA-cleared AI tool from Pathway Labs that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension.

Reviews & Opinions

No web reviews on file yet for Pathway Labs. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Pathway Labs.

Loading videos...

Videos load interactively. If none appear, search YouTube for Pathway Labs →

View all on YouTube

Press & Coverage

HLTH
Pathway Labs Raises $8.5M and Launches FDA-Approved EchoNext AI to Detect Hidden Heart Disease from ECGs
Pathway Labs announced an $8.5 million seed financing round and the launch of EchoNext, an FDA-approved AI platform that uses standard ECGs to identify patients at high risk for structural heart disease. The funding will support commercialization and broader deployment of the technology.
2026-06
Business Wire
Pathway Labs Announces World's First FDA Clearance for Multicondition AI in Cardiology and Partnership with OpenEvidence
Pathway Labs publicly launched EchoNext, the world's first FDA-approved AI detection tool for structural heart diseases using ECGs, with clearance for six indications. They also announced a partnership with OpenEvidence to integrate EchoNext into a platform used by many US clinicians.
2026-06
Medical Economics
FDA-cleared AI tool flags hidden heart disease from a standard ECG
Pathway Labs' new FDA-cleared AI tool can detect structural heart disease from routine ECGs, potentially catching conditions that are often undiagnosed until symptoms appear. The company also secured $8.5 million in seed funding to support deployment and continued R&D.
2026-06
Entrepreneur
Pathway raises funding at $500 mn valuation as 150M-parameter model challenges AI reasoning cost curve
AI lab Pathway (not explicitly 'Pathway Labs' but related to AI in healthcare) raised $30 million in funding at a $500 million valuation to enhance its 150M-parameter reasoning model BDH-CQ, aiming for cost efficiency in AI applications across various sectors, including healthcare.
2026-08
FinSMEs
Pathway Secures Additional Capital; Total Seed Funding Reaches $30M
Pathway, an AI research lab, secured additional capital, bringing its total seed funding to $30 million at a $500 million valuation. The funding will be used to expand compute capacity and accelerate the development of specialized reasoning models for financial services, technology, and healthcare.
2026-08
Business Wire
Pathway Expands Medical AI Platform with Drug Reference and Interaction Checker
Pathway launched a fully integrated drug reference and drug-drug interaction checker within its AI-powered medical knowledge platform. This allows clinicians to access comprehensive medication information and screen for interactions directly within their existing workflow.
2025-05
MDPI
PathCare: Integrating Clinical Pathway Information to Enable Healthcare Prediction at the Neuron Level
This paper introduces PathCare, a framework for learning future-predictive health representations to model long-term clinical pathways despite missing follow-ups. It utilizes a longitudinal-aware auxiliary sub-network and a neuron-level filtering mechanism.
2025-05
Business Wire
Pathway Raises $5M to Expand Its AI-Powered Medical Knowledge Platform
Pathway, an AI-driven medical knowledge platform, secured $5 million in seed funding to address information overload for healthcare professionals. The funding will accelerate the rollout of Pathway's technology and expand its reach to clinicians globally.
2023-11

Frequently Asked Questions

Pathway Labs offers EchoNext, an FDA-cleared AI screening tool that analyzes standard 12-lead electrocardiograms (ECGs) to detect signs of structural heart disease. It is cleared to identify six different types of heart disease, including right and left-sided heart failure, valve disease, severe hypertrophy compatible with infiltrative cardiomyopathy, and pulmonary hypertension.
Pathway Labs' EchoNext tool has received FDA clearance for its multi-condition AI system in cardiology, indicating it meets regulatory standards for safety and effectiveness. While specific details on HIPAA compliance for EchoNext aren't explicitly stated in the provided information, another company named Pathway (which may or may not be related) has introduced HIPAA-compliant access for its subscribers, supporting secure use of patient-specific information in AI queries.
The provided information does not detail the pricing structure for Pathway Labs' healthcare AI solutions like EchoNext for hospitals or clinics. However, a separate entity also named Pathway Labs, which focuses on school IT solutions, lists tiered pricing plans ranging from $600/month for basic features to custom plans for larger institutions, with a 10% implementation and onboarding fee. It's important to note that this pricing may not be applicable to the healthcare AI products.
While specific support details for Pathway Labs' healthcare AI are not extensively outlined, their partnership with OpenEvidence aims to expand access to EchoNext, making it available on a platform used by a significant number of US clinicians. This suggests that support may be integrated through the OpenEvidence platform, which offers clinical decision support and other features.
Pathway Labs has partnered with OpenEvidence to expand access to its EchoNext algorithm throughout the United States. OpenEvidence is an AI platform regularly used by over half of US clinicians, which will help integrate EchoNext into existing clinical workflows.
Pathway Labs has recently secured $8.5 million in seed funding led by AlleyCorp and Breyer Capital to expand its reach, support R&D, and deploy its technology across health systems. The company was founded by cardiologist Dr. Pierre Elias, who also serves as CEO and Medical Director for AI at NewYork-Presbyterian. Rachel Katz is the co-founder and Chief Operating Officer.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]

The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]

Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]

PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]

NeurixaHealthAI™ is a healthcare AI company dedicated to eliminating administrative waste in the healthcare system, which they estimate to be $1.1 trillion annually. They offer a production-ready healthcare intelligence platform designed to simplify operations, improve outcomes, and accelerate the journey from patient care to financial performance. The platform is not a collection of point solutions […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.